Emergency Medicine Pulmonary Embolism Testing Multicentre Study

NCT06320236 · tracked via the Priya Life Science Canada tracker

Sponsor

Dr. Kerstin de Wit

Phase

Observational

Started

2024-01-01

Last updated

2026-04-20

Condition(s) studied

Pulmonary EmbolismD-dimerDiagnosis

Investigational drug(s) / intervention(s)

Adjust-Unlikely

Adjust-Unlikely: Pulmonary embolism will be excluded during emergency department assessment by the combination of: 1. 'Pulmonary embolism is the most likely diagnosis' as per the treating physician AND a D-dimer result \< 500 ug/L fibrinogen equivalent units; 2. 'Pulmonary embolism is not the most likely diagnosis' AND D-dimer \< age-adjusted threshold; or, 3. A negative computed tomography scan, planar ventilation perfusion scan or ventilation perfusion-SPECT. Emergency departments will use their local laboratory D-dimer assay.

Study summary

It is important to diagnose pulmonary embolism in a timely manner to prevent death and long-term disability. More than half a million people (4-5% of emergency department patients) are tested for pulmonary embolism, although the positive rate is low. Imaging for PE testing exposes patients to radiation, is expensive, adds time to the emergency visit, and can lead to a false positive diagnoses. Existing protocols aimed at reducing unnecessary pulmonary embolism imaging are complex and seldom used by emergency physicians. Too many patients undergo unnecessary pulmonary embolism imaging.

A new tool (called Adjust-Unlikely) could safely reduce pulmonary embolism imaging in Canada. A research group composed of researchers, emergency physicians, and patients developed the Adjust-Unlikely clinical decision rule: a rule which has been customized for emergency physicians and emergency patients. Adjust-Unlikely is highly sensitive at the bedside, meaning there are very few false negative results.

The study aim is to prospectively validate Adjust-Unlikely pulmonary embolism testing in emergency patients with suspected pulmonary embolism.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Emergency department patient who is tested by an emergency physician for PE Exclusion Criteria: * Patient is \< 18 years of age * No documentation of whether PE is the most likely diagnosis * D-dimer is not tested or else not resulted during the emergency visit * The D-dimer level is known before documentation of whether PE is the most likely diagnosis * The D-dimer is ordered prior to the physician assessing the patient * The patient has previously registered that they opt out of all research at the participating site * The patient leaves against medical advice * The patient has had PE or deep vein thrombosis imaging (CT pulmonary angiogram, ventilation-perfusion scan or lower limb ultrasound) within prior 30 days * There is a new (non-PE) indication for anticoagulation * The patient was initiated on treatment for presumed PE prior to PE testing * The patient has previously been enrolled into the study * The patient has a prior history of lower extremity deep vein thrombosis without availability of a baseline ultrasound scan * The patient was transferred from another hospital organization * The patient does not reside in Ontario * The patient has no valid Ontario Health Insurance Plan card

Primary outcome measure(s)

Number of venous thrombosis events — 30 days

Trial sites (4)

Facility	City	Region	Status
Hamilton Health Sciences Corporation	Hamilton	Ontario	Recruiting
Kingston Health Sciences Centre	Kingston	Ontario	Recruiting
London Health Sciences Centre Research Inc	London	Ontario	Active Not Recruiting
Ottawa Hospital Research Institute	Ottawa	Ontario	Active Not Recruiting

More Dr. Kerstin de Wit trials in Canada

Falls Validation Study Recruiting

Superficial Vein Thrombosis Testing in the Emergency Department Starting soon

Selective CT for Anticoagulated Head Injured Patients Recruiting

Other trials for the same condition

Early Temporal Dynamics of Optic Nerve Sheath Diameter After Therapy in GCA Starting soon

Pulmonary Embolism International THrOmbolysis Study-3 Active, not recruiting

The PEERLESS II Study Active, not recruiting

Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer Recruiting

Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06320236 on ClinicalTrials.gov ↗ ← All trials in Canada